18F-Florbetaben PET beta-amyloid binding expressed in Centiloids
暂无分享,去创建一个
Vincent Doré | Colin L. Masters | Santiago Bullich | Victor L. Villemagne | Christopher C. Rowe | Rachel S. Mulligan | Susan De Santi | C. Rowe | C. Masters | S. de Santi | L. Dinkelborg | R. Mulligan | Gareth Jones | V. Villemagne | V. Doré | S. Bullich | Gareth Jones | A. Stephens | Ludger Dinkelborg | Andrew W. Stephens | David Baxendale | D. Baxendale | Susan de Santi
[1] Nelleke Tolboom,et al. Image-derived input functions for PET brain studies , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[2] M. Mintun,et al. Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods , 2013, The Journal of Nuclear Medicine.
[3] Victor L. Villemagne,et al. Brain Amyloid Imaging , 2011, The Journal of Nuclear Medicine.
[4] P. Vemuri,et al. Brain β-amyloid load approaches a plateau , 2013, Neurology.
[5] Nelleke Tolboom,et al. Evaluation of Tracer Kinetic Models for Analysis of [18F]FDDNP Studies , 2009, Molecular Imaging and Biology.
[6] Lennart Thurfjell,et al. The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data , 2015, Alzheimer's & Dementia.
[7] Gina N. LaRossa,et al. [11C]PIB in a nondemented population , 2006, Neurology.
[8] Masanori Ichise,et al. PET Quantification of 18F-Florbetaben Binding to β-Amyloid Deposits in Human Brains , 2013, The Journal of Nuclear Medicine.
[9] C. Rowe,et al. Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias , 2011, The Journal of Nuclear Medicine.
[10] C. Rowe,et al. Quantitative approaches to amyloid imaging. , 2011, Methods in molecular biology.
[11] L. Thurfjell,et al. Automated quantification of [18F]flutemetamol data - Comparison with standard of truth based on histopathology , 2013 .
[12] C. Rowe,et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.
[13] C. Rowe,et al. 18F-florbetaben Aβ imaging in mild cognitive impairment , 2013, Alzheimer's Research & Therapy.
[14] R. Coleman,et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study , 2012, The Lancet Neurology.
[15] John Seibyl,et al. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study , 2015, Alzheimer's & Dementia.
[16] C. Rowe,et al. 18 F-florbetaben Ab imaging in mild cognitive impairment , 2013 .
[17] John Seibyl,et al. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study , 2011, The Lancet Neurology.
[18] C. Rowe,et al. Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[19] John Seibyl,et al. Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[20] Paul Maruff,et al. Research and standardization in Alzheimer's trials: Reaching international consensus , 2013, Alzheimer's & Dementia.
[21] C. Rowe,et al. Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism , 2008, The Lancet Neurology.
[22] Rik Ossenkoppele,et al. Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images , 2014, The Journal of Nuclear Medicine.
[23] Robert A. Koeppe,et al. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET , 2015, Alzheimer's & Dementia.
[24] L. Thurfjell,et al. Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[25] C. Rowe,et al. Imaging β-amyloid burden in aging and dementia , 2007, Neurology.
[26] H. Kung,et al. F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain. , 2005, Journal of medicinal chemistry.
[27] R. Boellaard,et al. Test-retest variability of quantitative [11C]PIB studies in Alzheimer’s disease , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[28] S. DeKosky,et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.